Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tri-weekly Cisplatin CCRT in Advanced Cervical Cancer
NCT00916500Phase 2Completed
- Sponsor
- Korea Cancer Center Hospital
- Start
- Mar 2006
- Primary completion
- Dec 2013
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cisplatin micelle injection (HA132) in Cervical Cancer (CC), sponsored by Korea Cancer Center Hospital. Started Mar 2006; status: completed.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00916500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00916500.